Product Licensing

Areas of interest

Handok is looking for innovative and novel treatments which may bring synergistic effects with current portfolio in the areas below as a priority target.

Scroll left to right.

Areas of interest
Areas Main products/brands from current Handok Portfolio
  • Sulfonylurea: Amaryl, Amaryl M, Amaryl Mex
  • DPP-4 inhibitor: Tenelia, Tenelia M
  • SGLT-2 inhibitor: Suglat
  • Insulin: Glarzia
  • Insomnia: Stilnox
  • Epilepsy: Depakine
  • Schizophrenia: Solian
Orphan & Specialty
  • PNH, aHUS: Soliris
  • VOD: Defitelio
  • PAH: Opsumit, Uptravi, Tracleer
  • Hypertension: Teveten, Teveten Plus, Triapin
  • Myocardial infarction: Tritace, Tritace Plu
  • Benign prostatic hyperplasia: Xatral XL
  • Overactive bladder: Toviaz
  • Erectile dysfunction: Cialis
Medical Devices
  • Glucose monitoring: Barozen
  • Intraocular pressure: Triggerfish
  • Partners for diagnostics: Siemens, Arkray, Beckman Coulter
  • Lab supplies: Eppendorf, Qiagen
Consumer Health and Nutrition
  • Food supplements: Natureset
  • High-absorption curcumin: ReadyQ
  • Probiotics: Culturelle
  • Medical nutrition: Infatrini, Souvenaid

Existing Partners

Partnership is one of Handok’s main growth model. We are highly interested in various collaborative opportunities.